Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001477932-25-001257
Filing Date
2025-02-25
Accepted
2025-02-25 18:35:48
Documents
1
Period of Report
2025-02-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 6025
  Complete submission text file 0001477932-25-001257.txt   7721
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-484-8805
Matinas BioPharma Holdings, Inc. (Issuer) CIK: 0001582554 (see all company filings)

EIN.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1345 AVENUE OF THE AMERICAS 27TH FLOOR NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS 27TH FLOOR NEW YORK NY 10105 212-813-1010
Pembroke & Partners LLC (Reporting) CIK: 0002056785 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38022 | Film No.: 25665370